<div class="p4l_caption"><div class="p4l_captionTitle"><a target="_blank" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3226976/" ref="ordinalpos=912&amp;ncbi_uid=4408997&amp;link_uid=PMC3226976" image-link="/pmc/articles/PMC3226976/figure/F5/" class="imagepopup">Fig. 5. Phenotypes of potential acy-1 <span class="highlight" style="background-color:">signaling</span> <span class="highlight" style="background-color:">pathway</span> mutants.  From: A Gain-of-function Mutation in Adenylate Cyclase Confers Isoflurane Resistance in C. elegans. </a></div><br /><div class="p4l_captionBody">(A) Isoflurane EC50 values for various genes hypothesized to lie in the acy-1 signaling pathway (* p &lt; 0.01 vs. wild type). (B) js127 increases sensitivity of crh-1(n3315) to 0.35mM aldicarb (p &lt; 0.01). (C) Aldicarb resistance (0.35mM) of unc-10(md1117) is not significantly suppressed by js127. (D) Aldicarb resistance (0.35mM) of snb-1(md247) is not significantly suppressed by js127. (E) Aldicarb resistance (0.35mM) of unc-13(e376) is not significantly suppressed by js127. (F) js127 mutation enhances the locomotion of several lethargic mutants but not unc-13(s69) (* p &lt; 0.01 vs. lethargic single mutant).</div></div>